Barrett's esophagus and cardiac intestinal metaplasia: Two conditions within the same spectrum

Canadian Journal of Gastroenterology

Volumn 22, Issue 4, 2008, Pages 369-375

  White, Nicole ^a   Gabril, Manal ^b   Ejeckam, Gershon ^c   Mathews, Maria ^a   Fardy, John ^c   Kamel, Fady ^a   Doré, Jules ^a   Yousef, George M ^d,e  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c Eastern Health Canada   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Barrett's esophagus; Cardiac intestinal metaplasia; CK20; CK7; Dysplasia; H pylori

Indexed keywords

ALCIAN BLUE; CYTOKERATIN 20; CYTOKERATIN 7; EOSIN; HEMATOXYLIN;

ADULT; AGED; ANAMNESIS; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; ESOPHAGOSCOPY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 44649164499     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/243254     Document Type: Article

References (35)

1. Sarbia M, Donner A, Franke C, Gabbert HE. Distinction between intestinal metaplasia in the cardia and in Barrett's esophagus: The role of histology and immunohistochemistry. Hum Pathol 2004;35:371-6.
2. Terano A, Morita K, Nakamura T, Ohkura Y, Ono Y, Fujimori T. Barrett's esophagus. J Gastroenterol 2002;37:685-90.
3. El-Zimaity HM, Graham DY. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia. in the cardia using endoscopic biopsy specimens. Am J Gastroenterol 2001;96:1378-82.
4. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer fisk in Barrett's esophagus? Gastroenterology 2000;119:333-8.
5. DeMeester SR, Wickramasinghe KS, Lord RV, et al. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. Am J Gastroenterol 2002;97:2514-23.
6. Polkowski W, van Lanschot JJ, ten Kate FJ, et al. Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett's esophagus. Am J Gastroenterol 2000;95:617-25.
7. Cameron AJ, Lomboy CT. Barrett's ssophagus: Age, prevalence, and extent of columnar epithelium. Gastroenterology 1992;103:1241-5.
8. Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE. Dysplasia in short-segment Barrett's esophagus: A prospective 3-year follow-up. Am J Gastroenterol 1997;92:2012-6.
9. Spechler SJ. Clinical practice. Barrett's esophagus. N Engl J Med 2002;346:836-42.
10. Reis CA, David L, Correa P, et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 1999;59:1003-7.
11. Silva E, Teixeira A, David L, et al. Mucins as key molecules for the classification of intestinal metaplasia of the stomach. Virchows Arch 2002;440:311-7.
12. Morales TG, Sampliner RE, Bhattacharyya A. Intestinal metaplasia of the gastric cardia. Am J Gastroenterol 1997;92:414-8.
13. Goldblum JR, Vicari JJ, Falk GW, et al. Inflammation and intestinal metaptasia of the gastric cardia: The role of gastroesophageal reflux and H. Pylori infection. Gastroenterology 1998;114:633-9.
14. Odze R. Cytokeratin 7/20 immunostaining: Barrett's oesophagus or gastric intestinal metaplasia? Lancet 2002;359:1711-3.
15. Csendes A, Smok G, Quiroz J, et al. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compare to 174 cases of intestinal metaplasia of the cardia. Am J Gastroenterol 2002;97:554-60.
16. Sharma P, Weston AP, Morales T, Topalovski M, Mayo MS, Sampliner RE. Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut 2000;46:9-13.
17. Moll R, Franke WW, Schiller DL, Geiger B, Krepter R. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
18. Ormsby AH, Goldblum JR, Rice TW, et al. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Pathol 1999;30:288-94.
19. Glickman JN, Wang H, Das KM, et al. Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: An immunohistochemical study of cytokeratins 7 and 20. Das-1 and 45 MI. Am J Surg Pathol 2001;25:87-94.
20. Wallner B, Sylvan A, Janunger KG, Bozoky B, Stenling R. Immunohistochemical markers for Barrett's esophagus and associations to esophageal Z-Line appearance. Scand J Gastroenterol 2001;36:910-5.
21. Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1998;93:1028-32.
22. Terano A, Morita K, Nakamura T, Ohkura Y, Ono Y, Fujimori T. Barrett's esophagus. J Gastroenterol 2002;37:685-90.
23. Ormsby AH, Vaezi MF, Richter JE, et al. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. Gastroenterology 2000;119:683-90.
24. Hennekens C, Buring JE. Screening. In: Mayrent S, ed. Epidemiology in Medicine. Boston/Toronto: Little, Brown and Company, 1987:327-47.
25. Mohammed IA, Streutker CJ, Riddell RH. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia. Mod Pathol 2002;15:611-6.
26. Filipe MI, Munoz N, Matko I, et al. Intestinal metaplasia types and the risk of gastric cancer: A cohort study in Slovenia. Int J Cancer 1994;57:324-9.
27. Jass JR. Role of intestinal metaplasia in the histogenesis of gastric carcinoma. J Clin Pathol 1980;31:801-10.
28. Kato Y, Kitagawa T, Yanagisawa A, et al. Site-dependent development of complete and incomplete intestinal metaplasia types in the human stomach Jpn J Cancer Res 1992;83:178-83.
29. Jass JR. Mucin histochemistry the columnar epithelium of the oesophagus: A retrospective study. J Clin Pathol 1981;34:866-70.
30. Streitz JM Jr, Ellis FH Jr, Gibb SP, Balogh K, Watkins E Jr. Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann Surg 1991;213:122-5.
31. Parsonnet J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9(Suppl 2):45-51.
32. Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis 1993;168:219-21.
33. El-Serag HB, Sonnenberg A, Jamal MM, Kunkel D, Crooks L, Feddersen RM. Characteristics of intestinal metaplasia in the gastric cardia. Am J Gastroenterol 1999;94:622-7.
34. Goldblum JR, Richter JE, Vaezi M, Falk GW, Rice TW, Peek RM. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa. Am J Gastroenterol 2002;97:302-11.
35. Oberg S, Johansson J, Wenner J, Walther B. Metaptastic columnar mucosa in the cervical esophagus after esophagectomy. Ann Surg 2002;235:338-45.